|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0360 USD | 0.00% |
|
-1.37% | +38.46% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | -1.37% | +6.19% | +80.00% | +38.46% | -85.07% | -96.00% | -99.10% | -99.59% | 9.54M | |
| -1.97% | +6.31% | +4.32% | -12.81% | -14.12% | +23.19% | -4.27% | +13.14% | +78.46% | 68.8B | |
| -2.01% | -5.08% | -4.71% | -5.58% | +4.23% | +46.38% | +217.46% | +179.44% | +268.88% | 55.21B | |
| -4.15% | +36.30% | +36.30% | +36.30% | +36.30% | +36.30% | +36.30% | +36.30% | - | 43.46B | |
| +0.27% | +8.33% | +26.95% | -11.41% | -28.00% | -49.87% | -53.43% | -55.79% | +11.96% | 41.18B | |
| -7.48% | +5.38% | +55.56% | +47.28% | +150.25% | +146.82% | -37.92% | -66.74% | - | 31.65B | |
| -2.60% | -7.27% | +2.57% | +14.09% | +13.85% | +53.97% | -27.16% | -43.61% | -18.97% | 30.37B | |
| -0.67% | +3.44% | +14.53% | +25.16% | +18.72% | +74.31% | +88.92% | +42.77% | +40.38% | 23.58B | |
| -1.15% | +8.29% | +12.53% | -5.79% | +13.05% | +4.42% | +184.96% | -0.23% | - | 19.33B | |
| -1.33% | +2.47% | +6.00% | +20.40% | +42.25% | +65.52% | +132.74% | +189.10% | +339.55% | 17.16B | |
| +0.54% | +5.17% | +15.86% | +8.90% | +2.41% | +80.07% | +363.77% | +22.18% | - | 15.27B | |
| -1.68% | +0.33% | +5.70% | +45.53% | +34.46% | +128.44% | +237.79% | +286.91% | +3,250.20% | 12.85B | |
| -7.11% | -13.16% | -5.71% | -11.44% | -30.26% | -24.82% | +712.18% | +298.94% | +4,823.01% | 11.93B | |
| -0.99% | +4.42% | +5.25% | +6.28% | +0.54% | +4.08% | -29.76% | -28.05% | -32.23% | 11.66B | |
| +1.84% | +1.00% | +24.72% | +42.20% | +52.27% | +168.64% | +211.15% | +464.00% | - | 10.87B | |
| -4.95% | -5.65% | +31.63% | -17.96% | +21.95% | +38.37% | +325.32% | +272.35% | - | 6.95B | |
| -0.49% | +0.45% | -0.64% | -0.53% | -15.89% | -14.20% | -26.56% | -59.46% | -55.22% | 6.24B | |
| -3.12% | +4.80% | +12.88% | -30.26% | -26.80% | -27.90% | +142.80% | +101.37% | +123.48% | 5.83B | |
| -4.10% | +10.73% | +15.15% | -0.08% | -7.67% | +16.41% | +66.36% | -37.08% | - | 5.74B | |
| -1.81% | -13.12% | +29.12% | +78.33% | +181.78% | +151.14% | +358.36% | -29.39% | - | 5.67B | |
| Average | -1.81% | +1.24% | +14.71% | +15.43% | +24.39% | +41.81% | +140.15% | +74.35% | +727.49% | 21.19B | |
| Weighted average by Cap. | -1.79% | +2.67% | +15.03% | +9.27% | +18.54% | +43.31% | +97.72% | +58.86% | +443.32% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
